AIM logo
Alcohol in
Moderation
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • Cognitive decline
  • Parkinsons’ disease& alcohol
  • Rheumatoid arthritis& alcohol
  • Stroke
  • Women& alcohol
    • Breast cancer
    • Pregnancy
Choose a Topic
January 2019
Heart
,
Moderate drinking

Light to moderate alcohol consumption is associated with an enzyme that may be protective for cardiovascular disease

Authors of a study published in the American Journal of Clinical Nutrition state that paraoxonase‐1 (PON‐1), an enzyme associated with high‐density lipoprotein (HDL) that has antioxidative properties, may protect against the development of cardiovascular disease. Alcohol consumption increases HDL cholesterol, but the extent to which alcohol consumption gives rise to higher serum PON‐1 activity is uncertain.
In their population‐based study, researchers determined the relation of serum PON‐1 activity with alcohol consumption when taking account of HDL cholesterol and apolipoprotein A‐I (apoA‐I), its major apolipoprotein. A cross‐sectional study was performed in 8,224 participants of the Prevention of Renal and Vascular End‐Stage Disease (PREVEND) cohort. Alcohol consumption was categorised as 1) no/rarely (25.3%); 2) 0.1‐10
g/d (49.3%); 3) 10‐30 g/d (20.1%); and 4) >30 g/d (5.2%). Serum PON‐1 activity was measured as its arylesterase activity (phenyl acetate as substrate).” “The median serum PON‐1 activity was 50.8, 53.1, 54.4, and 55.7 U/L in the 4 categories of alcohol consumption, respectively. Its increase paralleled the increments in HDL cholesterol and apoA‐I. Notably, there was no further increase in PON‐1 activity, HDL cholesterol, and apoA‐I when alcohol consumption was increased from 10‐30 g/d to >30 g/d. Multivariable linear regression analysis demonstrated that PON‐1 activity was related to alcohol consumption independently from clinical covariates, high sensitivity C‐reactive protein, and lipid concentrations, including HDL cholesterol.
The authors conclude that alcohol consumption is associated with an increase in serum PON‐1 activity, but its effect seems to reach a plateau with alcohol consumption of 10‐30 g/d.
Source: Serum paraoxonase‐1 activity is associated with light to moderate alcohol consumption: the PREVEND cohort study. Gruppen EG; Bakker SJ; James RW; Dullaart RP. American Journal of Clinical Nutrition, Vol 108, No 6, 2018, pp1283‐1290. doi.or”
doi.org/10.1093/ajcn/nqy217
Drinking & You logo
Drinking & You
A global portal providing advice about responsible alcohol consumption, individual country government guidelines and your health.
Go to website
International Scientific Forum on Alcohol Research logo
International Scientific Forum on Alcohol Research
The International Scientific Forum on Alcohol Research (ISFAR) is a group of 45 specialist Professors and Medics who produce balanced and well researched analysis of emerging research papers alcohol and health.
Go to website

To receive notification of updates to the website, please subscribe here

Name(Required)

Topics

Harmful consumption

& alcohol

Healthy lifestyle

& alcohol

Genetics

& alcohol

Depression

& alcohol

All-cause mortality

& alcohol

Cancer

& alcohol

Diabetes

& alcohol

Heart

& alcohol

Antioxidants

& alcohol

Bone mineral density

& alcohol

The brain

& alcohol

General health

& alcohol

Gut health

& alcohol

J-shaped curve

& alcohol

The kidneys

& alcohol

The liver

& alcohol

Mediterranean diet

& alcohol

Metabolic syndrome/weight

& alcohol

Moderate drinking

Old age

& alcohol

Parkinsons' disease

& alcohol

Rheumatoid arthritis

& alcohol

Stroke

& alcohol

Women

& alcohol

Latest articles

Preventable cancer cases and deaths attributable to alcohol consumption in Korea from 2015 to 2030

Alcohol consumption and ambulatory blood pressure-lowering effect in male patients on clinic blood pressure-guided antihypertensive treatment

Influence of binge drinking on the resting state functional connectivity of university students

The relationship between alcohol intake and all-cause mortality in participants with MASLD and MetALD

Healthy lifestyle habits, educational attainment, and the risk of 45 age-related health and mortality outcomes in the UK

Aim Digest

June 2025

February 2025

January 2025

December 2024

November 2024

© Alcohol In Moderation, 2025.
Web design by Rubber Duckers
Close menu
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
Close menu
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • ← Back
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • ← Back
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • ← Back
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • ← Back
    • Cognitive decline
  • Parkinsons’ disease& alcohol
  • Rheumatoid arthritis& alcohol
  • Stroke
  • Women& alcohol
    • ← Back
    • Breast cancer
    • Pregnancy